In addition, the methylation pattern of the HAND2 gene was investigated in endometrial cancer, and it was revealed that the alterations in HAND2 DNA methylation commonly occur in endometrial cancer and could be utilized as a biomarker for early detection and a predictor of treatment response [27]. The gene discussed is HAND2; the disease is endometrial cancer.